ClinicalTrials.gg
CompletedNCT02926391Updated May 3, 2023

UNiD 3D VBR Register

An observational study in Spinal Cord Compression, Spondylosis and Ossification of Posterior Longitudinal Ligament, sponsored by Medicrea International. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-03.

Sponsored by Medicrea International (part of Medtronic) · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
18 Years and older
Sex
All
01

Study summary

Multicenter study allowing to include the first sixty patients implanted with a custom-made corpectomy implant (UNiD 3D VBR): 30 patient implanted in cervical region and 30 patients implanted in thoracolumbar region.

The main objective is to confirm feasibilty and safety of patient-specific implants for one or multi-level corpectomy and fusion.

This study was approved in March 2016 allowing to include retrospectivley all patients since the first implantation in January 2015 and prospectively all patients after the approval.

Read the detailed description

Anterior cervical corpectomy with fusion (ACCF) has been demonstrated as a good alternative to anterior cervical discectomy and fusion (ACDF) to treat cervical spondylotic myelopathy (CSM). However, the use of vertebral body replacement (VBR) cages is technically demanding, especially to adjust the size of the cage to the defect without compromising the endplate integrity increasing the risk of subsidence. Beside recent studies advocating the interest of the shape, size and design of an implant to achieve fusion and stability in cervical spinal diseases indications, 3D printing offering rapid and patient-specific manufacturing has emerged over the past years. Several materials and technologies can be used and clinical and radiological data are still sparse.

02

Conditions studied

  • Spinal Cord Compression
  • Spondylosis
  • Ossification of Posterior Longitudinal Ligament
  • Spinal Neoplasms
  • Bone Disease, Infectious
03

In context

Spinal Cord Compression

52 studies on the registry are indexed under Spinal Cord Compression; 19 are open to participants now.

This study's enrollment of 12 is below the median of 70 across 17 observational studies indexed under Spinal Cord Compression.

Browse Spinal Cord Compression studies →

Lead sponsor

Medicrea International is the lead sponsor of 8 studies on the registry; none are open to participants now.

First submitted before Medicrea International became part of Medtronic.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who need single or multilevel corpectomy and fusion and who received a patient specific implants UNiD 3D VBR

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients who underwent a single or multilevel cervical or thoracolumbar coprectomy and implanted with a patient specific implant (UNiD 3D VBR) for the following indications:

    • Cervical region

      • Fracture / Trauma
      • Tumors
      • Cervical spondylotic myelopathy
      • Infection (Ex: Osteomyelitis)
      • Spinal instability
      • Symptomatic degenerative spinal disease
      • Inflammatory rheumatism.
      • Pseudarthrosis
    • Thoracolumbar region

      • Fracture / Trauma
      • Tumors
      • Infection (Ex: Osteomyelitis)
      • Spinal instability
      • Symptomatic degenerative spinal disease
      • Pseudarthrosis
  2. Patients > 18 years
  3. Patients who signed an Form

Exclusion criteria

Exclusion Criteria:

  1. Patients who can't or doesn't want to sign an ICF
  2. Patients unable to fill HRQOL questionnaires
  3. Non-compliant paitents regarding follow-up or protocol
  4. Pregnant patient or intended to be pregnant within the next 2 years
  5. Sytemic or local infection
  6. Allergy known or suspected to a componant
  7. Patients presenting a as indicated in the instruction for use
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (actual)
Target follow-up
24 Months
Patient registry
Yes

Groups and cohorts

  • Cervical

    30 patients who need anterior cervical corpectomy and fusion with patient-specific implants (UNiD 3D VBR)

    Device: UNiD 3D VBR

  • Thoraco-lumbar

    30 patients who need anterior thoracolumbar corpectomy and fusion with patient-specific implants (UNiD 3D VBR)

    Device: UNiD 3D VBR

Interventions

  • DeviceUNiD 3D VBR

    Corpectomy of one or several vertebral body(ies) followed by vertebral body(ies) replacement and fusion

    Also known as: Patient-specific corpectomy implants, Custom-made corpectomy implants

06

What researchers measure

Primary outcomes

  1. Quantification and description of implant-related adverse events

    To confirm the safety of the surgery with patient specfic implant (UNiD 3D VBR). To quantify and describe adverse events or revision surgeries occuring during follow-up

    Time frame: 12 months

Secondary outcomes

  1. Fusion status

    Radiological assessment of bony fusion

    Time frame: 6, 12, 24 months

  2. Length of surgery

    Surgeon questionnaire will be used to quantify surgery's length

    Time frame: During surgery

  3. Surgical metrics

    Surgeon questionnaire will be used to describe the surgery

    Time frame: During surgery

  4. Quality of life

    mJOA: Modified Japanese Orthopaedic Association Score

    Time frame: preoperatively and 6,12, and 24 months postoperation

  5. Quality of life

    EMS: European Myelopathy Score

    Time frame: preoperatively and 6,12, and 24 months postoperation

  6. Pain

    Visual Analog Score

    Time frame: preoperatively and 6,12, and 24 months postoperation

  7. Disability

    Neck disability index

    Time frame: preoperatively and 6,12, and 24 months postoperation

  8. Variation of radiological vertebral heights

    Xrays assessment of segmental height operated

    Time frame: 6,12, 24 months

  9. Variation of radiological vertebral angulation

    Xrays assessment of C2C7 angle and corpectomy angles

    Time frame: 6,12, 24 months postoperativley

07

Study locations

1 site
  • CHU Tours
    Tours, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2016 to primary completion in Mar 2018, 17 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2016
First posted
Oct 6, 2016
StartActual
Oct 2016
Primary completionActual
Mar 2018
CompletionActual
Mar 2018
Last update
May 3, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02926391
Responsible party
Sponsor
First posted
Oct 6, 2016
Start date
Oct 2016
Primary completion
Mar 2018
Completion
Mar 2018
Last update
May 3, 2023

Study contacts

Jean-Edouard Loret, MD
principal investigator · CHU Tours

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion